Reversal of apixaban anticoagulation by four‐factor prothrombin complex concentrates in healthy subjects: a randomized three‐period crossover study
Work
Year: 2017
Type: article
Institution Bristol-Myers Squibb (United States)
Cites: 42
Cited by: 47
Related to: 10
FWCI: 5.886
Citation percentile (by year/subfield): 92.61
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed
Funders Bristol-Myers Squibb, Pfizer